Posts

Showing posts from February, 2023

Combining a chemical blocker of immune cell exit with immunotherapy stops skin cancer growth

The number of specialized immune cells available for fighting skin cancer doubled when a new treatment blocked their escape from melanoma tumors, experiments in mice and human cells show. source https://www.news-medical.net/news/20230227/Combining-a-chemical-blocker-of-immune-cell-exit-with-immunotherapy-stops-skin-cancer-growth.aspx

Skin medication shows promise in treating alcohol use disorder

Researchers from Oregon Health & Science University and institutions across the country have identified a pill used to treat a common skin disease as an "incredibly promising" treatment for alcohol use disorder. source https://www.news-medical.net/news/20230221/Skin-medication-shows-promise-in-treating-alcohol-use-disorder.aspx

New and surprising evidence that ChatGPT can perform several intricate tasks relevant to handling complex medical and clinical information

Researchers evaluated the performance of an AI model named ChatGPT to perform clinical reasoning on the United States Medical Licensing Exam (USMLE). source https://www.news-medical.net/news/20230213/New-and-surprising-evidence-that-ChatGPT-can-perform-several-intricate-tasks-relevant-to-handling-complex-medical-and-clinical-information.aspx

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. source https://www.news-medical.net/news/20230207/Immunosuppressive-drug-methotrexate-linked-to-increased-risk-of-three-types-of-skin-cancer.aspx